カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

デクスランソプラゾール徐放性カプセルのグローバル市場2023：30MG、60MG

■ 英語タイトル：Global Dexlansoprazole Sustained Release Capsule Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11404）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11404
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：71
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[デクスランソプラゾール徐放性カプセルのグローバル市場2023：30MG、60MG]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、デクスランソプラゾール徐放性カプセルのグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界のデクスランソプラゾール徐放性カプセル市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- デクスランソプラゾール徐放性カプセルの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

デクスランソプラゾール徐放性カプセル市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・30MG、60MG

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・TAKEDA PHARM、PAR PHARM、TWI PHARM

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、デクスランソプラゾール徐放性カプセル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なデクスランソプラゾール徐放性カプセルメーカーの企業概要、2019年～2022年までのデクスランソプラゾール徐放性カプセルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なデクスランソプラゾール徐放性カプセルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別デクスランソプラゾール徐放性カプセルの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのデクスランソプラゾール徐放性カプセルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのデクスランソプラゾール徐放性カプセル市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびデクスランソプラゾール徐放性カプセルの産業チェーンを掲載しています。
・第14、15章では、デクスランソプラゾール徐放性カプセルの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– デクスランソプラゾール徐放性カプセルの概要
– 種類別分析（2018年vs2022年vs2029年）：30MG、60MG
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界のデクスランソプラゾール徐放性カプセル市場規模・予測
– 世界のデクスランソプラゾール徐放性カプセル生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– TAKEDA PHARM、PAR PHARM、TWI PHARM
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：30MG、60MG
・用途別分析2018年-2029年：病院、診療所
・デクスランソプラゾール徐放性カプセルの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・デクスランソプラゾール徐放性カプセルのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・デクスランソプラゾール徐放性カプセルのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・デクスランソプラゾール徐放性カプセルの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・デクスランソプラゾール徐放性カプセルの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Dexlansoprazole Sustained Release Capsule
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 30MG
1.3.3 60MG
1.4 Market Analysis by Application
1.4.1 Overview: Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Dexlansoprazole Sustained Release Capsule Market Size & Forecast
1.5.1 Global Dexlansoprazole Sustained Release Capsule Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Dexlansoprazole Sustained Release Capsule Sales Quantity (2018-2029)
1.5.3 Global Dexlansoprazole Sustained Release Capsule Average Price (2018-2029)
2 Manufacturers Profiles
2.1 TAKEDA PHARM
2.1.1 TAKEDA PHARM Details
2.1.2 TAKEDA PHARM Major Business
2.1.3 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product and Services
2.1.4 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 TAKEDA PHARM Recent Developments/Updates
2.2 PAR PHARM
2.2.1 PAR PHARM Details
2.2.2 PAR PHARM Major Business
2.2.3 PAR PHARM Dexlansoprazole Sustained Release Capsule Product and Services
2.2.4 PAR PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 PAR PHARM Recent Developments/Updates
2.3 TWI PHARM
2.3.1 TWI PHARM Details
2.3.2 TWI PHARM Major Business
2.3.3 TWI PHARM Dexlansoprazole Sustained Release Capsule Product and Services
2.3.4 TWI PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TWI PHARM Recent Developments/Updates
3 Competitive Environment: Dexlansoprazole Sustained Release Capsule by Manufacturer
3.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Manufacturer (2018-2023)
3.2 Global Dexlansoprazole Sustained Release Capsule Revenue by Manufacturer (2018-2023)
3.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Dexlansoprazole Sustained Release Capsule by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Dexlansoprazole Sustained Release Capsule Manufacturer Market Share in 2022
3.4.2 Top 6 Dexlansoprazole Sustained Release Capsule Manufacturer Market Share in 2022
3.5 Dexlansoprazole Sustained Release Capsule Market: Overall Company Footprint Analysis
3.5.1 Dexlansoprazole Sustained Release Capsule Market: Region Footprint
3.5.2 Dexlansoprazole Sustained Release Capsule Market: Company Product Type Footprint
3.5.3 Dexlansoprazole Sustained Release Capsule Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Dexlansoprazole Sustained Release Capsule Market Size by Region
4.1.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2018-2029)
4.1.2 Global Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2018-2029)
4.1.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Region (2018-2029)
4.2 North America Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
4.3 Europe Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
4.4 Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
4.5 South America Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
4.6 Middle East and Africa Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
5.2 Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type (2018-2029)
5.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
6.2 Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application (2018-2029)
6.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Application (2018-2029)
7 North America
7.1 North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
7.2 North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
7.3 North America Dexlansoprazole Sustained Release Capsule Market Size by Country
7.3.1 North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
7.3.2 North America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
8.2 Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
8.3 Europe Dexlansoprazole Sustained Release Capsule Market Size by Country
8.3.1 Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
8.3.2 Europe Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Dexlansoprazole Sustained Release Capsule Market Size by Region
9.3.1 Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
10.2 South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
10.3 South America Dexlansoprazole Sustained Release Capsule Market Size by Country
10.3.1 South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
10.3.2 South America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Dexlansoprazole Sustained Release Capsule Market Size by Country
11.3.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Dexlansoprazole Sustained Release Capsule Market Drivers
12.2 Dexlansoprazole Sustained Release Capsule Market Restraints
12.3 Dexlansoprazole Sustained Release Capsule Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Dexlansoprazole Sustained Release Capsule and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dexlansoprazole Sustained Release Capsule
13.3 Dexlansoprazole Sustained Release Capsule Production Process
13.4 Dexlansoprazole Sustained Release Capsule Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dexlansoprazole Sustained Release Capsule Typical Distributors
14.3 Dexlansoprazole Sustained Release Capsule Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. TAKEDA PHARM Basic Information, Manufacturing Base and Competitors
Table 4. TAKEDA PHARM Major Business
Table 5. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product and Services
Table 6. TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. TAKEDA PHARM Recent Developments/Updates
Table 8. PAR PHARM Basic Information, Manufacturing Base and Competitors
Table 9. PAR PHARM Major Business
Table 10. PAR PHARM Dexlansoprazole Sustained Release Capsule Product and Services
Table 11. PAR PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. PAR PHARM Recent Developments/Updates
Table 13. TWI PHARM Basic Information, Manufacturing Base and Competitors
Table 14. TWI PHARM Major Business
Table 15. TWI PHARM Dexlansoprazole Sustained Release Capsule Product and Services
Table 16. TWI PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. TWI PHARM Recent Developments/Updates
Table 18. Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 19. Global Dexlansoprazole Sustained Release Capsule Revenue by Manufacturer (2018-2023) & (USD Million)
Table 20. Global Dexlansoprazole Sustained Release Capsule Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Market Position of Manufacturers in Dexlansoprazole Sustained Release Capsule, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 22. Head Office and Dexlansoprazole Sustained Release Capsule Production Site of Key Manufacturer
Table 23. Dexlansoprazole Sustained Release Capsule Market: Company Product Type Footprint
Table 24. Dexlansoprazole Sustained Release Capsule Market: Company Product Application Footprint
Table 25. Dexlansoprazole Sustained Release Capsule New Market Entrants and Barriers to Market Entry
Table 26. Dexlansoprazole Sustained Release Capsule Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2018-2023) & (K Units)
Table 28. Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2024-2029) & (K Units)
Table 29. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2018-2023) & (USD Million)
Table 30. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2024-2029) & (USD Million)
Table 31. Global Dexlansoprazole Sustained Release Capsule Average Price by Region (2018-2023) & (US$/Unit)
Table 32. Global Dexlansoprazole Sustained Release Capsule Average Price by Region (2024-2029) & (US$/Unit)
Table 33. Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2023) & (K Units)
Table 34. Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2024-2029) & (K Units)
Table 35. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Global Dexlansoprazole Sustained Release Capsule Average Price by Type (2018-2023) & (US$/Unit)
Table 38. Global Dexlansoprazole Sustained Release Capsule Average Price by Type (2024-2029) & (US$/Unit)
Table 39. Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2024-2029) & (K Units)
Table 41. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application (2018-2023) & (USD Million)
Table 42. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application (2024-2029) & (USD Million)
Table 43. Global Dexlansoprazole Sustained Release Capsule Average Price by Application (2018-2023) & (US$/Unit)
Table 44. Global Dexlansoprazole Sustained Release Capsule Average Price by Application (2024-2029) & (US$/Unit)
Table 45. North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2023) & (K Units)
Table 46. North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2024-2029) & (K Units)
Table 47. North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2023) & (K Units)
Table 48. North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2024-2029) & (K Units)
Table 49. North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2023) & (K Units)
Table 50. North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2024-2029) & (K Units)
Table 51. North America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2023) & (USD Million)
Table 52. North America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2023) & (K Units)
Table 56. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2024-2029) & (K Units)
Table 57. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2023) & (K Units)
Table 58. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2024-2029) & (K Units)
Table 59. Europe Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2023) & (K Units)
Table 62. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2024-2029) & (K Units)
Table 63. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2023) & (K Units)
Table 64. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2024-2029) & (K Units)
Table 65. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2018-2023) & (K Units)
Table 66. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2024-2029) & (K Units)
Table 67. Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2018-2023) & (USD Million)
Table 68. Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2024-2029) & (USD Million)
Table 69. South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2023) & (K Units)
Table 70. South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2024-2029) & (K Units)
Table 71. South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2023) & (K Units)
Table 72. South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2024-2029) & (K Units)
Table 73. South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2023) & (K Units)
Table 74. South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2024-2029) & (K Units)
Table 75. South America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2023) & (USD Million)
Table 76. South America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2024-2029) & (USD Million)
Table 77. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2023) & (K Units)
Table 78. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2024-2029) & (K Units)
Table 79. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2018-2023) & (K Units)
Table 82. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2024-2029) & (K Units)
Table 83. Middle East & Africa Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2018-2023) & (USD Million)
Table 84. Middle East & Africa Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2024-2029) & (USD Million)
Table 85. Dexlansoprazole Sustained Release Capsule Raw Material
Table 86. Key Manufacturers of Dexlansoprazole Sustained Release Capsule Raw Materials
Table 87. Dexlansoprazole Sustained Release Capsule Typical Distributors
Table 88. Dexlansoprazole Sustained Release Capsule Typical Customers
List of Figures
Figure 1. Dexlansoprazole Sustained Release Capsule Picture
Figure 2. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Type in 2022
Figure 4. 30MG Examples
Figure 5. 60MG Examples
Figure 6. Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Dexlansoprazole Sustained Release Capsule Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Dexlansoprazole Sustained Release Capsule Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Dexlansoprazole Sustained Release Capsule Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Dexlansoprazole Sustained Release Capsule Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Dexlansoprazole Sustained Release Capsule by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Dexlansoprazole Sustained Release Capsule Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Dexlansoprazole Sustained Release Capsule Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Dexlansoprazole Sustained Release Capsule Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Dexlansoprazole Sustained Release Capsule Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Region (2018-2029)
Figure 52. China Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Dexlansoprazole Sustained Release Capsule Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Dexlansoprazole Sustained Release Capsule Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Dexlansoprazole Sustained Release Capsule Market Drivers
Figure 73. Dexlansoprazole Sustained Release Capsule Market Restraints
Figure 74. Dexlansoprazole Sustained Release Capsule Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Dexlansoprazole Sustained Release Capsule in 2022
Figure 77. Manufacturing Process Analysis of Dexlansoprazole Sustained Release Capsule
Figure 78. Dexlansoprazole Sustained Release Capsule Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • デクスランソプラゾール徐放性カプセルの世界市場2023-2029：30MG、60MG
  • グリクラジド徐放性錠剤のグローバル市場2023：30mg、60mg、その他
  • グリクラジド徐放性錠剤の世界市場2023-2029：30mg、60mg、その他
  • ダポキセチン塩酸塩錠剤の世界市場2023-2029：30mg、60mg
  • 多成分コデインのグローバル市場展望 2023年-2029年：15mg、30mg、60mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11404 )"デクスランソプラゾール徐放性カプセルのグローバル市場2023：30MG、60MG" (英文：Global Dexlansoprazole Sustained Release Capsule Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。